Charles River Laboratories International, Inc. (CRL)
USD 183.16
(-3.26%)
USD 183.16
(-3.26%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.06 Billion USD | -1.0% |
| 2022 | 3.09 Billion USD | 6.2% |
| 2021 | 2.91 Billion USD | 39.87% |
| 2020 | 2.08 Billion USD | 6.07% |
| 2019 | 1.96 Billion USD | 20.12% |
| 2018 | 1.63 Billion USD | 46.9% |
| 2017 | 1.11 Billion USD | -7.75% |
| 2016 | 1.2 Billion USD | 42.75% |
| 2015 | 845.99 Million USD | 13.41% |
| 2014 | 745.95 Million USD | 16.13% |
| 2013 | 642.35 Million USD | 21.86% |
| 2012 | 527.13 Million USD | -25.04% |
| 2011 | 703.18 Million USD | 4.91% |
| 2010 | 670.27 Million USD | 46.53% |
| 2009 | 457.41 Million USD | -15.39% |
| 2008 | 540.64 Million USD | 11.47% |
| 2007 | 484.99 Million USD | -11.35% |
| 2006 | 547.08 Million USD | 110.24% |
| 2005 | 260.21 Million USD | -57.06% |
| 2004 | 605.98 Million USD | 226.35% |
| 2003 | 185.68 Million USD | -3.53% |
| 2002 | 192.48 Million USD | 23.49% |
| 2001 | 155.86 Million USD | -23.03% |
| 2000 | 202.5 Million USD | -47.06% |
| 1999 | 382.5 Million USD | 31989.01% |
| 1998 | 1.19 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 2.63 Billion USD | -14.15% |
| 2024 Q2 | 2.38 Billion USD | -9.49% |
| 2023 Q2 | 3.08 Billion USD | -2.59% |
| 2023 FY | 3.06 Billion USD | -1.0% |
| 2023 Q3 | 2.9 Billion USD | -5.7% |
| 2023 Q1 | 3.16 Billion USD | 2.09% |
| 2023 Q4 | 3.06 Billion USD | 5.57% |
| 2022 Q3 | 3.3 Billion USD | 11.44% |
| 2022 Q1 | 2.94 Billion USD | 0.82% |
| 2022 FY | 3.09 Billion USD | 6.2% |
| 2022 Q4 | 3.09 Billion USD | -6.31% |
| 2022 Q2 | 2.96 Billion USD | 0.88% |
| 2021 Q2 | 2.96 Billion USD | 24.9% |
| 2021 Q4 | 2.91 Billion USD | -7.02% |
| 2021 FY | 2.91 Billion USD | 39.87% |
| 2021 Q1 | 2.37 Billion USD | 13.92% |
| 2021 Q3 | 3.13 Billion USD | 5.73% |
| 2020 Q4 | 2.08 Billion USD | -1.4% |
| 2020 Q1 | 2.46 Billion USD | 25.14% |
| 2020 Q3 | 2.11 Billion USD | -10.18% |
| 2020 Q2 | 2.35 Billion USD | -4.3% |
| 2020 FY | 2.08 Billion USD | 6.07% |
| 2019 Q3 | 1.99 Billion USD | -6.95% |
| 2019 Q2 | 2.14 Billion USD | 30.23% |
| 2019 FY | 1.96 Billion USD | 20.12% |
| 2019 Q4 | 1.96 Billion USD | -1.68% |
| 2019 Q1 | 1.64 Billion USD | 0.81% |
| 2018 Q1 | 1.12 Billion USD | 1.39% |
| 2018 Q3 | 1.65 Billion USD | -8.0% |
| 2018 Q4 | 1.63 Billion USD | -0.98% |
| 2018 FY | 1.63 Billion USD | 46.9% |
| 2018 Q2 | 1.79 Billion USD | 59.04% |
| 2017 Q2 | 1.11 Billion USD | -4.6% |
| 2017 Q4 | 1.11 Billion USD | -3.62% |
| 2017 FY | 1.11 Billion USD | -7.75% |
| 2017 Q1 | 1.17 Billion USD | -3.12% |
| 2017 Q3 | 1.15 Billion USD | 3.56% |
| 2016 Q2 | 1.33 Billion USD | 58.37% |
| 2016 FY | 1.2 Billion USD | 42.75% |
| 2016 Q3 | 1.23 Billion USD | -7.35% |
| 2016 Q4 | 1.2 Billion USD | -2.07% |
| 2016 Q1 | 840.48 Million USD | -0.65% |
| 2015 Q1 | 754.53 Million USD | 1.15% |
| 2015 FY | 845.99 Million USD | 13.41% |
| 2015 Q4 | 845.99 Million USD | 1.22% |
| 2015 Q3 | 835.8 Million USD | 10.73% |
| 2015 Q2 | 754.77 Million USD | 0.03% |
| 2014 Q1 | 614.12 Million USD | -4.39% |
| 2014 Q2 | 781.61 Million USD | 27.27% |
| 2014 FY | 745.95 Million USD | 16.13% |
| 2014 Q4 | 745.95 Million USD | -1.17% |
| 2014 Q3 | 754.79 Million USD | -3.43% |
| 2013 FY | 642.35 Million USD | 21.86% |
| 2013 Q3 | 624.31 Million USD | 0.73% |
| 2013 Q1 | 518.03 Million USD | -1.73% |
| 2013 Q2 | 619.77 Million USD | 19.64% |
| 2013 Q4 | 642.35 Million USD | 2.89% |
| 2012 Q2 | 551.39 Million USD | -18.28% |
| 2012 FY | 527.13 Million USD | -25.04% |
| 2012 Q1 | 674.74 Million USD | -4.05% |
| 2012 Q4 | 527.13 Million USD | -2.95% |
| 2012 Q3 | 543.14 Million USD | -1.5% |
| 2011 Q2 | 731.41 Million USD | -3.92% |
| 2011 Q4 | 703.18 Million USD | -2.4% |
| 2011 FY | 703.18 Million USD | 4.91% |
| 2011 Q1 | 761.29 Million USD | 13.58% |
| 2011 Q3 | 720.48 Million USD | -1.5% |
| 2010 Q2 | 409.44 Million USD | -6.5% |
| 2010 Q1 | 437.91 Million USD | -4.26% |
| 2010 FY | 670.27 Million USD | 46.53% |
| 2010 Q4 | 670.27 Million USD | -4.39% |
| 2010 Q3 | 701.07 Million USD | 71.23% |
| 2009 Q1 | 474.15 Million USD | -12.3% |
| 2009 FY | 457.41 Million USD | -15.39% |
| 2009 Q4 | 457.41 Million USD | -1.36% |
| 2009 Q3 | 463.74 Million USD | -4.67% |
| 2009 Q2 | 486.48 Million USD | 2.6% |
| 2008 Q3 | 303.68 Million USD | -2.75% |
| 2008 Q1 | 476.36 Million USD | -1.78% |
| 2008 FY | 540.64 Million USD | 11.47% |
| 2008 Q4 | 540.64 Million USD | 78.03% |
| 2008 Q2 | 312.26 Million USD | -34.45% |
| 2007 Q4 | 484.99 Million USD | -1.76% |
| 2007 Q1 | 527.55 Million USD | -3.57% |
| 2007 FY | 484.99 Million USD | -11.35% |
| 2007 Q3 | 493.69 Million USD | -3.54% |
| 2007 Q2 | 511.81 Million USD | -2.98% |
| 2006 Q1 | 270.65 Million USD | 4.01% |
| 2006 FY | 547.08 Million USD | 110.24% |
| 2006 Q4 | 547.08 Million USD | -5.11% |
| 2006 Q3 | 576.54 Million USD | 0.83% |
| 2006 Q2 | 571.8 Million USD | 111.27% |
| 2005 FY | 260.21 Million USD | -57.06% |
| 2005 Q4 | 260.21 Million USD | -12.6% |
| 2005 Q3 | 297.72 Million USD | -8.58% |
| 2005 Q2 | 325.67 Million USD | -44.4% |
| 2005 Q1 | 585.77 Million USD | -3.33% |
| 2004 FY | 605.98 Million USD | 226.35% |
| 2004 Q4 | 605.98 Million USD | 225.86% |
| 2004 Q3 | 185.96 Million USD | -0.09% |
| 2004 Q2 | 186.13 Million USD | -0.05% |
| 2004 Q1 | 186.22 Million USD | 0.29% |
| 2003 Q3 | 189.76 Million USD | -0.06% |
| 2003 Q4 | 185.68 Million USD | -2.15% |
| 2003 FY | 185.68 Million USD | -3.53% |
| 2003 Q2 | 189.86 Million USD | 0.01% |
| 2003 Q1 | 189.84 Million USD | -1.37% |
| 2002 Q1 | 259.52 Million USD | 66.5% |
| 2002 FY | 192.48 Million USD | 23.49% |
| 2002 Q4 | 192.48 Million USD | 2.07% |
| 2002 Q3 | 188.58 Million USD | -0.24% |
| 2002 Q2 | 189.04 Million USD | -27.16% |
| 2001 Q1 | 230.7 Million USD | 13.93% |
| 2001 Q2 | 201.7 Million USD | -12.57% |
| 2001 FY | 155.86 Million USD | -23.03% |
| 2001 Q3 | 193.65 Million USD | -3.99% |
| 2001 Q4 | 155.86 Million USD | -19.51% |
| 2000 Q3 | 202.78 Million USD | -48.45% |
| 2000 Q1 | 390.46 Million USD | 0.0% |
| 2000 Q2 | 393.36 Million USD | 0.74% |
| 2000 Q4 | 202.5 Million USD | -0.14% |
| 2000 FY | 202.5 Million USD | -47.06% |
| 1999 FY | 382.5 Million USD | 31989.01% |
| 1998 FY | 1.19 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Agilent Technologies, Inc. | 2.73 Billion USD | -12.116% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | 30.468% |
| Danaher Corporation | 17.66 Billion USD | 82.638% |
| Enzo Biochem, Inc. | 189 Thousand USD | -1622323.81% |
| IQVIA Holdings Inc. | 12.95 Billion USD | 76.331% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | 24.375% |
| Mettler-Toledo International Inc. | 1.88 Billion USD | -62.361% |
| Qiagen N.V. | 921.82 Million USD | -232.643% |
| Revvity, Inc. | 3.17 Billion USD | 3.505% |
| Thermo Fisher Scientific Inc. | 31.3 Billion USD | 90.206% |
| Waters Corporation | 2.3 Billion USD | -33.002% |